WallStreetZenWallStreetZen

NASDAQ: PAVM
Pavmed Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$0.71+0.03 (+4.41%)
Updated Apr 17, 2025
PAVM Price
$0.71
Fair Value Price
N/A
Market Cap
$11.92M
52 Week Low
$0.55
52 Week High
$2.43
P/E
0.22x
P/B
-4.78x
P/S
2.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.00M
Earnings
$39.79M
Gross Margin
-61.6%
Operating Margin
1,330.08%
Profit Margin
1,067.3%
Debt to Equity
-15.11
Operating Cash Flow
-$34M
Beta
1.23
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

PAVM Overview

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PAVM's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
PAVM
RankedUnranked of 102

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Bioventus (BVS)
$7.82A
Electromed (ELMD)
$22.79A
Tactile Systems Technology (TCMD)
$13.33A
View Top Medical Device Stocks

Be the first to know about important PAVM news, forecast changes, insider trades & much more!

PAVM News

Overview

Due Diligence Score

–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PAVM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PAVM is good value based on its earnings relative to its share price (0.22x), compared to the US market average (27.98x)
P/E vs Market Valuation
PAVM is good value based on its earnings relative to its share price (0.22x), compared to the US Medical Devices industry average (41.14x)
P/E vs Industry Valuation
PAVM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PAVM due diligence checks available for Premium users.

Valuation

PAVM price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0.22x
Industry
41.14x
Market
27.98x
PAVM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PAVM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

PAVM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-4.78x
Industry
3.8x

PAVM's financial health

Profit margin

Revenue
$10.0k
Net Income
$1.4M
Profit Margin
13,460%
PAVM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PAVM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$30.7M
Liabilities
$37.7M
Debt to equity
-15.11
PAVM's short-term liabilities ($35.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PAVM's long-term liabilities ($2.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PAVM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PAVM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$94.0k
Investing
-$4.0k
Financing
$330.0k
PAVM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PAVM vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PAVM–$11.92M+4.41%0.22x-4.78x
CODX–$11.65M+2.97%-0.28x0.21x
VVOSC$12.37M+0.96%-0.95x1.55x
SSKN–$10.55M+0.32%-0.95x2.12x
AXDX–$13.84M-1.79%-0.26x-0.25x
View Top Medical Device Stocks

Pavmed Stock FAQ

What is Pavmed's quote symbol?

(NASDAQ: PAVM) Pavmed trades on the NASDAQ under the ticker symbol PAVM. Pavmed stock quotes can also be displayed as NASDAQ: PAVM.

If you're new to stock investing, here's how to buy Pavmed stock.

What is the 52 week high and low for Pavmed (NASDAQ: PAVM)?

(NASDAQ: PAVM) Pavmed's 52-week high was $2.43, and its 52-week low was $0.55. It is currently -70.78% from its 52-week high and 29.09% from its 52-week low.

How much is Pavmed stock worth today?

(NASDAQ: PAVM) Pavmed currently has 16,787,173 outstanding shares. With Pavmed stock trading at $0.71 per share, the total value of Pavmed stock (market capitalization) is $11.92M.

Pavmed stock was originally listed at a price of $195.00 in Jul 28, 2016. If you had invested in Pavmed stock at $195.00, your return over the last 8 years would have been -99.64%, for an annualized return of -50.44% (not including any dividends or dividend reinvestments).

How much is Pavmed's stock price per share?

(NASDAQ: PAVM) Pavmed stock price per share is $0.71 today (as of Apr 17, 2025).

What is Pavmed's Market Cap?

(NASDAQ: PAVM) Pavmed's market cap is $11.92M, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pavmed's market cap is calculated by multiplying PAVM's current stock price of $0.71 by PAVM's total outstanding shares of 16,787,173.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.